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The audio version of this Blood Advances Talk is available on the full-text article page.

Abstract
The high incidence of thromboembolic disease, and in particular venous thromboembolism
(VTE), has emerged as an important consideration in hospitalized and critically ill patients
with coronavirus disease 2019 (COVID-19). The coagulopathy of COVID-19 is postulated to
result from interactions of the inﬂammatory and immune systems with the coagulation
system, manifesting as a cytokine storm associated with hyperinﬂammation and
coagulation and platelet activation. Unique characteristics of VTE in hospitalized and
critically ill patients with COVID-19 include the high incidence of VTE (and especially
pulmonary embolism) when compared with historical controls; the ﬁnding of in situ
pulmonary embolism associated with microthrombi, which suggests a thrombotic
microangiopathic process in addition to classic macrovessel disease; and, most important
from a clinical perspective, the unusually high rate of VTE that has been reported despite
standard thromboprophylaxis. This raises the possibility that intermediate or weight-based
heparin dosing may be more effective than ﬁxed dosing for thromboprophylaxis in high-risk
subsets of patients hospitalized with COVID-19. There have been several guidance
statements focusing on the management of VTE in hospitalized and critically ill patients with
COVID-19, including the most recent statement by the Scientiﬁc and Standardization
Committee of the International Society of Thrombosis and Haemostasis, which includes
comprehensive guidance on the diagnosis, prevention, and treatment of VTE in this patient
population. Ongoing randomized trials that address key clinical questions, especially more
intense thromboprophylactic strategies and novel antithrombotic approaches, have the
potential to reduce the morbidity and mortality from VTE in hospitalized and critically ill
patients with COVID-19.
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